Yasmin Hurd, PhD: Asking the Questions No One Was Asking
A couple of decades ago, most people familiar with cannabis called it marijuana—and had probably never heard of cannabidiol (also known as CBD), one of its components. Today, many people have heard about CBD and its potential therapeutic uses thanks to the work of...
Mount Sinai Launches Center for Engineering and Precision Medicine: What Is it and Why Does it Matter?
The opening of the Center for Engineering and Precision Medicine (CEPM) brings together biomedical experts from the Icahn School of Medicine at Mount Sinai and engineering experts from Rensselaer Polytechnic Institute under the same roof. The center, located on the...
New Center for Engineering and Precision Medicine Paves the Way for Two Fields to Work More Closely Together
The Icahn School of Medicine at Mount Sinai and the Rensselaer Polytechnic Institute on May 12 announced the opening of the Center for Engineering and Precision Medicine (CEPM), forming a new venture to bridge engineering and biomedical science expertise between the...
SARS-CoV-2: Three Leading Microbiologists Discuss the Path Forward
Microbiologists at the Icahn School of Medicine at Mount Sinai, who created the first and most reliable test to determine whether an individual has antibodies to SARS-CoV-2, have been monitoring the virus since it began circulating in Wuhan, China, in late 2019. Now,...
Milestone Gift From Marc and Jennifer Lipschultz Elevates Precision Immunology Research at Mount Sinai
The Mount Sinai Health System has announced a transformative multimillion-dollar gift from Marc Lipschultz, who serves on Mount Sinai’s Boards of Trustees, and his wife, Jennifer, to the Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount...
Advancing Artificial Intelligence Through Philanthropy
Thanks to the outstanding generosity of the Windreich Family Foundation, the Icahn School of Medicine at Mount Sinai will advance its vision of integrating Artificial Intelligence (AI) and machine learning into research and clinical practice to amplify...
Mount Sinai Neuroscience Student Earns NIH Fellowship to Study Substance Use Disorders
Can the bacteria in your gut influence addictive behavior? That is the question that Katherine Meckel is studying and trying to answer. Currently a fifth-year PhD candidate in neuroscience at the Icahn School of Medicine at Mount Sinai, Ms. Meckel is one of 31 young...
Mount Sinai Researchers Describe a Novel Approach to Harness Fecal Microbiota Transplantation That Could Be Safer and More Precise
In a study published in Nature Microbiology, researchers at the Icahn School of Medicine at Mount Sinai address unanswered questions about how fecal microbiota transplantation (FMT) can effectively restore a patient’s microbiome. FMT involves transferring processed...
Brain Researcher Ian Maze Has Upended Scientific Dogma and Forged New Areas for Therapeutic Discovery
For decades, scientific dogma held that the chemicals dopamine and serotonin served as messengers within the central nervous system, allowing brain cells, or neurons, to communicate with each other. Known as neurotransmitters, dopamine and serotonin also contribute to...